Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person12
Definitive Healthcare Corp.
Company
TENET HEALTHCARE CORP
Company
NATIONAL HEALTHCARE CORP
Company
Healthcare AI Acquisition Corp.
Company
CVS HEALTH Corp
Company
HCA Healthcare, Inc.
Company
Syra Health Corp
Company
DAVION HEALTHCARE PLC
Company
Community Healthcare Trust Inc
Company
Optimi Health Corp.
Company
ETHEMA HEALTH Corp
Company
DIVERSIFIED HEALTHCARE TRUST
Company
Primary record18
Encompass Health Corp filed 8-K
ITEM 7.01. Regulation FD Disclosure. On November 6, 2026, Encompass Health Corporation (“Encompass Health” or the “Company”) issued the press release, attached to this report as Exhibit 99.1 and incorporated herein by re
Definitive Healthcare Corp. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 5, 2026, Definitive Healthcare Corp. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30,
SENSIENT TECHNOLOGIES CORP filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d). On October 29, 2026, the Board of Directors (the “Board”)
Definitive Healthcare Corp. filed 4
SEC form 4 filed by Definitive Healthcare Corp. (CIK 1861795) on 2026-11-03.
Definitive Healthcare Corp. filed 4
SEC form 4 filed by Definitive Healthcare Corp. (CIK 1861795) on 2026-11-03.
Definitive Healthcare Corp. filed 4
SEC form 4 filed by Definitive Healthcare Corp. (CIK 1861795) on 2026-10-27.
SARATOGA INVESTMENT CORP. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On October 8, 2026, Saratoga Investment Corp. (the Company ) and its wholly owned financing subsidiary, Saratoga Investment Funding II LLC ( SIF II or the Borrower )
BioNexus Gene Lab Corp filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On October 5, 2026, BioNexus Gene Lab Corp. (the "Company") entered into a CogniAI Healthcare Licence and Strategic Collaboration Agreement (the "Agreement") with Ru
Definitive Healthcare Corp. filed 4
SEC form 4 filed by Definitive Healthcare Corp. (CIK 1861795) on 2026-10-05.
Definitive Healthcare Corp. filed 4
SEC form 4 filed by Definitive Healthcare Corp. (CIK 1861795) on 2026-10-05.
Definitive Healthcare Corp. filed SCHEDULE 13D/A
("SEC") on August 10, 2026. Y Advent International GP, LLC b OO DE 0.00 62493676.00 0.00 62493676.00 62493676.00 58.54 OO The reported percentage is calculated based on 106,744,713 shares of Common Stock outstanding as o
TENET HEALTHCARE CORP filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. The information set forth below in Item 2.03 is incorporated by reference into this Item 1.01. Item 2.03. Creation of a Direct Financial Obligation or an Obligation
PERDOCEO EDUCATION Corp filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On September 14, 2026, Perdoceo Education Corporation, a Delaware corporation (the “Company”), entered into a Membership Interest Purchase Agreement (the “Purchase A
Addus HomeCare Corp filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 12, 2026, Addus HealthCare, Inc., an Illinois corporation ( Addus HealthCare ), a wholly-owned subsidiary of Addus HomeCare Corporation (the Company ), e
Definitive Healthcare Corp. filed 8-K
Item 7.01 Regulation FD Disclosure. As previously disclosed, Definitive Healthcare Corp. (the Company ) is party to a tax receivable agreement, dated as of September 14, 2021 (the TRA ), with AIDH TopCo, LLC, certain aff
Definitive Healthcare Corp. filed 4
SEC form 4 filed by Definitive Healthcare Corp. (CIK 1861795) on 2026-09-03.
Definitive Healthcare Corp. filed SCHEDULE 13D
on Form 10-Q filed with the Securities and Exchange Commission ("SEC") on August 10, 2026), and includes (i) 41,457 shares of Class A Common Stock that are issuable to the Reporting Person upon vesting of restricted stoc
Definitive Healthcare Corp. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Chief Executive Officer On August 28, 2026, the